Research

New worldwide estimates for herpes simplex virus type 2 published

New global estimates for herpes simplex virus type 2 show that over 400-million people worldwide were infected with the virus in 2012. The estimates underline the extent to which herpes simplex virus type 2 – the virus which causes genital herpes – is widespread throughout the world causing a significant burden of disease. The research, led by University of Bristol academics and the World Health Organisation [WHO], is published in the journal PLOS ONE.

£2.5 million for largest trial to improve outcomes from treatment for blocked leg arteries

Blocked leg arteries – often caused by diabetes or smoking – are very common, but if left untreated can lead to amputation, or even death. To improve blood flow, a procedure called an angioplasty is usually carried out, with patients given blood-thinning drugs afterwards. A new trial led by North Bristol NHS Trust, in collaboration with the University of Bristol and the Centre for Trials Research at Cardiff University, will compare three commonly prescribed blood-thinning tablets to find out which works best.